Trial
NCT04233697
Copanlisib in Combination With Romidepsin in Patients With Relapsed or Refractory Mature T-cell Lymphoma
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Columbia University
Collaborators
Bayer
Condition
Lymphoma, T-Cell
Intervention
Copanlisib
Why stopped
Investigator left institution
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-08-13